Matthias Wulf

Matthias Wulf

Matthias is a Principal at the BioInnovation Institute in Copenhagen where he anchors several therapeutics and women’s health companies. Prior to joining BII, Matthias worked as an investment analyst at the corporate VC, M Ventures, in Amsterdam, as a pharmacist...
Preben Bruun-Nyzell

Preben Bruun-Nyzell

Preben is 2N Pharma’s co-founder and CEO and brings broad business and finance experience from an international career spanning nine countries over 25 years. He is co-founder of clinical-stage vaccine company 2A Pharma, and chairman...
John Nieland, PhD

John Nieland, PhD

John is 2N Pharma’s co-founder and CSO and brings broad management experience and a strong scientific background. He was previously director of research at Medigene AG. Next, he is co-founder of the clinical-stage vaccine company 2A Pharma. In addition to...
Angelique Corthals, MD, PhD

Angelique Corthals, MD, PhD

Angelique is a biological/biomedical and forensic anthropologist and biomedical researcher who studies the link between neurodegeneration, pathogens and metabolism as well as the histomorphology of trauma. She is associate professor at City University of New York, USA...
Anne Skøttrup Mørkholt, PhD

Anne Skøttrup Mørkholt, PhD

Anne completed her doctorate at the Laboratory of Metabolism Modifying Medicine, Aalborg University. She researched the connection between dysfunction of the lipid metabolism and CNS diseases, including multiple sclerosis and depression.
Steinunn Sara Helgudóttir, PhD

Steinunn Sara Helgudóttir, PhD

Steinunn completed her doctorate at the Neurobiology Research and Drug Delivery Group at Aalborg University. She conducted research on targeted drug delivery through the blood-brain barrier.